Lang Wu, Ph.D., conducts research on the epidemiological investigation of genetic, molecular, nutritional, and lifestyle factors in the etiology and prognosis of chronic diseases, with a particular focus on cancer. His long-term research goal is to translate this knowledge into strategies for the prevention, risk assessment, early detection, and prognosis prediction of chronic diseases. Wu's research has been supported by grants from the National Cancer Institute, National Human Genome Research Institute, National Institute on Minority Health and Health Disparities, the V Foundation, and others.

A primary focus of Wu’s current work is conducting integrative multi-omics studies (genomics, transcriptomics, methylomics, proteomics, metabolomics, etc.) to identify novel susceptibility genes and biomarkers for chronic diseases. He has led several large transcriptome-wide association studies that evaluate the associations of genetically predicted gene expression levels with the risks of prostate, pancreatic, and breast cancers, identifying multiple novel susceptibility gene candidates for these cancers. Additionally, Wu has explored DNA methylation, protein, and metabolite biomarkers associated with human diseases using genetic instruments, identifying several novel biomarker candidates for prostate and pancreatic cancer. Furthermore, Wu is investigating disease risk prediction through the integration of genetic, molecular, and other information.

Lunch will be provided.

RSVP HERE by Januay 24.

This even is part of the Dr. Herbert and Nicole Wertheim Leadership in Healthcare in Medicine Lecture Series.